Jimenez, A. E., Cicalese, K. V., Jimenez, M. A., Chakravarti, S., Kuo, C. C., Lozinsky, S., Schwab, J. H., Knowlton, S. E., Rowan, N. R., & Mukherjee, D. (2024). Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey. Neurosurgical Focus, 56(5), E12. https://doi.org/10.3171/2024.2.focus2410

Koerner, A. S., Zhou, M., Brook, A., Yoon, S. S., & Ganjoo, K. N. (2023). Response to Immunotherapy in Sclerosing Epithelioid Fibrosarcoma: Case Report and Literature Review. Cureus. https://doi.org/10.7759/cureus.50967

Dermawan, J. K. T., Nafa, K., Mohanty, A., Xu, Y., Rijo, I., Casanova, J., Villafania, L., Benhamida, J., Kelly, C. M., Tap, W. D., Boland, P. J., Fabbri, N., Healey, J. H., Ladanyi, M., Lu, C., & Hameed, M. (2023). Distinct IDH1/2-associated Methylation Profile and Enrichment ofTP53andTERTMutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer Research Communications, 3(3), 431–443. https://doi.org/10.1158/2767-9764.crc-22-0397

Sharma, R. K., Irace, A. L., Overdevest, J. B., Turner, J. H., Patel, Z. M., & Gudis, D. A. (2022). Association of Race, Ethnicity, and Socioeconomic Status With Esthesioneuroblastoma Presentation, Treatment, and Survival. OTO Open, 6(1). Portico. https://doi.org/10.1177/2473974x221075210